glp 1 drugs australia Ozempic, Wegovy, Saxenda and Mounjaro compared RACGP - Is the first

Let's break it down from a clinical perspective

INTRODUCTION Dulaglutide received approval from the Korean Ministry of Food and Drug Safety in 2015 and was widely used until a shortage occurred in early 2023

There is currently no established evidence that microdosing GLP-1 medications prevents Alzheimers disease or dementia

however, these studies are not conclusive

Interestingly, the influence on RAAS should also be considered in the clinical practice during the screening of suspected hyperaldosteronism due to the interfering regulation of sodium and water balance or mimicking the effects of beta-blockers (SGLT2-i)